7[3]Taylor JS,Langston JW,Reddick WE,et al.Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis[J].Int J Radiat Oncol Biol Phys,1996,36(5):1251～1261
8[4]Tsui EY,Chan JG,Ramsey RG,et al.Late temporal lobe necrosis in patients with nasopharyngeal carcinoma:evaluation with combined multi-section diffusion weighted and perfusion weighted MR imaging[J].EurJ Radiol,2001,39(3):133～138
9[5]Sugahara T,Korogi Y,Tomiguchi S,et al.Posttherapeutic intraaxial brain tumor:the value of perfusion-sensitive contrastenhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue [J].AJNR,2000,21 (5):901～909
10[6]Ricci PE,Karis JP,Heiserman JE,et al.Differentiating recurrent tumor from radiation necrosis:time for re-evaluation of positron emission tomography?[J].AJNR,1998,19(3):407～413
7NICE technology appraisal guidance 121.Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade gli-oma[J].Nat Inst Clin Excel,J2007,6:3.
8Davis FG,Kupelian V,Freels S,et al.Prevalence estimates for pri-mary brain tumors in the United States by behavior and major his-tology groups[J].Neurooncology,2001;3:152-158.
9Walker MD,Green SB,Byar DP,et al.Randomized comparison ofradiotherapy and nitrosoureas for the malignant glioma after surgery[J].N Eng J Med,1980,303:1323-1329.
10Kita M,Okawa T,Tanaka M,et al.Radiotherapy of malignant glio-ma-prospective randomized clinical study of whole brain vs localirradiation[J].Gan No Rinsho,1989,35:1289-1294.
